Today: 23 March 2026
Subscribe
Browse Category

NYSE:MFG 27 November 2025 - 12 March 2026

Oil Prices Surge Again: Brent Crude Near $100, WTI Jumps as Hormuz Stays Shut

Oil Prices Surge Again: Brent Crude Near $100, WTI Jumps as Hormuz Stays Shut

Brent crude rose 8% to $99.38 after Iran said the Strait of Hormuz would remain shut and tanker attacks in Iraqi waters deepened supply fears. The International Energy Agency expects global supply to fall by 8 million barrels a day in March, calling it the biggest disruption on record. U.S. gasoline inventories fell 3.7 million barrels last week as drivers rushed to fill up. TotalEnergies reported a 15% output loss after shutdowns in the UAE, Qatar, and Iraq.
12 March 2026
··
Mizuho Financial Group Stock (8411 / MFG) Today: BOJ Rate-Hike Bets, Buybacks, and Analyst Forecasts — December 15, 2025

Mizuho Financial Group Stock (8411 / MFG) Today: BOJ Rate-Hike Bets, Buybacks, and Analyst Forecasts — December 15, 2025

Mizuho Financial Group shares closed at ¥5,852 in Tokyo on December 15, 2025, up 2.29% and near a 52-week high, as Japan’s BOJ Tankan survey boosted expectations for a rate hike. U.S.-listed ADRs traded around $7.60. Investors rotated into Japanese banks amid anticipated BOJ tightening and global tech selloffs. Reuters and Mizuho cited higher rates and shareholder returns as key drivers.
15 December 2025
··
Mizuho Financial Group (MFG) Stock Today, 27 November 2025: Price Action, Buyback Momentum and Outlook

Mizuho Financial Group (MFG) Stock Today, 27 November 2025: Price Action, Buyback Momentum and Outlook

Mizuho Financial shares traded near a record ¥5,555 in Tokyo on Nov. 27, after half-year net income jumped 22% and management raised its full-year profit forecast to ¥1.13 trillion. The stock is up 43% over 12 months. U.S.-listed ADRs closed at $7.09 on Nov. 26, with U.S. markets shut for Thanksgiving. No new corporate announcements were made Wednesday.
27 November 2025
··

Stock Market Today

  • Alto Neuroscience Raises $120 Million in Private Placement to Advance Psychiatric Drug Development
    March 23, 2026, 9:43 AM EDT. Alto Neuroscience secured $120 million through a private placement to fund development of ALTO-207, aimed at matching psychiatric patients with effective medications. CFO Nick Smith is set to discuss the financing on NYSE Live. The funding boost reflects growing investor interest in personalized psychiatric treatment amid evolving healthcare priorities. The update came during a broader NYSE pre-market briefing, highlighting stock gains after President Trump postponed strikes on Iran energy targets. The organization also noted KPMG's AI workplace survey and the start of the RSAC cybersecurity conference.
Go toTop